• Issue

    Respirology: Volume 23, Issue 5

    439-547
    May 2018

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 439-443
  • First Published: 16 April 2018

ORIGINAL ARTICLES

Asthma and Allergy

Comparison of respiratory system impedance in asthma and COPD: A prospective observational study

  • Pages: 478-484
  • First Published: 17 January 2018

Changes in a single assessment of within-breath variations of respiratory system reactance (Xrs) at 5 Hz (ΔX5) in patients with chronic obstructive pulmonary disease (COPD) are significantly greater than in patients with asthma. ΔX5 may reflect the pathophysiological changes in COPD and can be useful for its long-term assessment.

COPD

The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study

  • Pages: 485-491
  • First Published: 12 October 2017

This longitudinal analysis of a large chronic obstructive pulmonary disease (COPD) study explored the identification of clusters and their behaviour over 2 years. We validated previous data on the topic but in a multicentre study and with 2 years of follow-up (previously only 1 year). We also identified factors associated with cluster changes.

Critical Care

Models of care for non-invasive ventilation in the Acute COPD Comparison of three Tertiary hospitals (ACT3) study

  • Pages: 492-497
  • First Published: 10 December 2017

Although non-invasive ventilation (NIV) is an established treatment for acute hypercapnic COPD, the optimal model of care is not known. We undertook a comparison of NIV delivery in general, high dependency and intensive care wards and identified equal efficacy, with considerable financial savings using the general ward model.

Interstitial Lung Disease

Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis

  • Pages: 498-506
  • First Published: 14 November 2017

We evaluated 4 m gait speed (4MGS), a simple functional performance test, in people with stable idiopathic pulmonary fibrosis. We found 4MGS a reliable, valid and responsive measure that can detect a patient phenotype with worse dyspnoea, exercise performance, quality of life and prognostic risk.

Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease

  • Pages: 507-511
  • First Published: 27 November 2017
Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease

See related Editorial

This study addresses the utility and safety of surgical lung biopsies in diagnosing interstitial lung disease in patients older than 75 years. More than one-third of the patients with a computed tomography pattern incompatible with usual interstitial pneumonia had diagnoses other than idiopathic pulmonary fibrosis. The mortality in our cohort was higher than that reported in the literature.

Lung Function

Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry

  • Pages: 512-518
  • First Published: 15 November 2017

See related Editorial

Multiple breath nitrogen washout (MBNW) or impulse oscillometry system (IOS) abnormalities were highly prevalent in smokers without COPD but highly discordant between individuals. Cough was related to peripheral conductive airway function, while wheeze was related to IOS and spirometry. In smokers with normal spirometry, MBNW and IOS abnormalities may have different underlying structural bases and prognostic significance.

Pleural Disease

The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis

  • Pages: 519-525
  • First Published: 12 November 2017

See related Editorial

We evaluated prognostic significance of pneumothorax and the risk factors for its onset in patients with idiopathic pulmonary fibrosis (IPF). We demonstrate that the onset of pneumothorax predicts a poor outcome in the patients with IPF. Lower BMI and the presence of extensive reticular abnormalities are associated with developing pneumothorax.

Respiratory Infections

Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy

  • Pages: 526-534
  • First Published: 14 December 2017
Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy

See related Editorial

Limited studies have been performed to assess antibiotic effects in pneumonia according to drug-resistant pathogen (DRP) risk. Our results suggest that β-lactam plus macrolide combination therapy reduces mortality in patients with community-onset pneumonia at low DRP risk.

LETTER FROM ASIA-PACIFIC REGION

Free Access

Letter from Taiwan

  • Pages: 535-537
  • First Published: 25 March 2018